1. Home
  2. CLNE vs TRML Comparison

CLNE vs TRML Comparison

Compare CLNE & TRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLNE
  • TRML
  • Stock Information
  • Founded
  • CLNE 2001
  • TRML 2021
  • Country
  • CLNE United States
  • TRML United States
  • Employees
  • CLNE N/A
  • TRML N/A
  • Industry
  • CLNE Natural Gas Distribution
  • TRML Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLNE Utilities
  • TRML Health Care
  • Exchange
  • CLNE Nasdaq
  • TRML Nasdaq
  • Market Cap
  • CLNE 526.3M
  • TRML 598.9M
  • IPO Year
  • CLNE 2007
  • TRML N/A
  • Fundamental
  • Price
  • CLNE $2.59
  • TRML $47.70
  • Analyst Decision
  • CLNE Strong Buy
  • TRML Hold
  • Analyst Count
  • CLNE 5
  • TRML 12
  • Target Price
  • CLNE $3.59
  • TRML $47.04
  • AVG Volume (30 Days)
  • CLNE 1.3M
  • TRML 1.6M
  • Earning Date
  • CLNE 11-05-2025
  • TRML 11-06-2025
  • Dividend Yield
  • CLNE N/A
  • TRML N/A
  • EPS Growth
  • CLNE N/A
  • TRML N/A
  • EPS
  • CLNE N/A
  • TRML N/A
  • Revenue
  • CLNE $420,579,000.00
  • TRML N/A
  • Revenue This Year
  • CLNE $1.46
  • TRML N/A
  • Revenue Next Year
  • CLNE $2.46
  • TRML N/A
  • P/E Ratio
  • CLNE N/A
  • TRML N/A
  • Revenue Growth
  • CLNE 4.08
  • TRML N/A
  • 52 Week Low
  • CLNE $1.30
  • TRML $11.56
  • 52 Week High
  • CLNE $3.67
  • TRML $47.70
  • Technical
  • Relative Strength Index (RSI)
  • CLNE 53.03
  • TRML 59.15
  • Support Level
  • CLNE N/A
  • TRML N/A
  • Resistance Level
  • CLNE $2.61
  • TRML $47.70
  • Average True Range (ATR)
  • CLNE 0.10
  • TRML 1.08
  • MACD
  • CLNE -0.11
  • TRML 0.52
  • Stochastic Oscillator
  • CLNE 95.74
  • TRML 99.96

About CLNE Clean Energy Fuels Corp.

Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas, liquefied natural gas for the United States (U.S.) and Canadian transportation markets. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The company operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. The company also builds, operates, and maintains natural gas fueling stations for customers. The company's target markets include heavy-duty trucking, airports, public transit, institutional energy users, and government fleets.

About TRML Tourmaline Bio Inc.

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.

Share on Social Networks: